BMS-986463

N/A

Report date: 2026/01/22 16:42:36
NME

Base Information

Drug NameBMS-986463
Drug Alias NameBMS-986463
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase WEE1 degraders
TargetsSerine/threonine-protein kinase WEE1
Therapy Area/Indicationsuterine serous carcinomaCarcinoma, Non-Small-Cell LungCarcinoma, Ovarian Epithelial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb Srlcompany
Inactive CompaniesN/A
Active Indicationsuterine serous carcinomaCarcinoma, Non-Small-Cell LungCarcinoma, Ovarian Epithelial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A